You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Burkett's lymphoma

Showing 1 - 25 of 5,065
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Lymphoma, T-Cell, Cutaneous, Hodgkin Disease, Lymphoma, T-Cell, Peripheral Trial (SGN-35T)

Not yet recruiting
  • Lymphoma, T-Cell, Cutaneous
  • +5 more
  • (no location specified)
Nov 2, 2023

Obinutuzumab in Chinese Real-world Patients With iNHL

Not yet recruiting
  • Lymphomas Non-Hodgkin's B-Cell
  • Changzhou, Jiangsu, China
  • +24 more
Jul 23, 2023

Chronic Lymphocytic Leukemia, Mantle Cell Lymphoma, Follicular Lymphoma Trial in United States (Zilovertamab vedotin)

Active, not recruiting
  • Chronic Lymphocytic Leukemia
  • +11 more
  • Zilovertamab vedotin
  • Duarte, California
  • +13 more
Jan 12, 2023

Hematological Malignancies - SANGUINE

Recruiting
  • Hematologic Malignancy
  • Blood sampling for HemaChip screening/diagnostic testing
  • Bone marrow sampling
  • Olomouc, Czechia
  • +3 more
Feb 9, 2023

Lymphoid Malignancies, Multiple Myeloma, Lymphoma Trial in Boston, New York (Pralatrexate, Romidepsin)

Unknown status
  • Lymphoid Malignancies
  • +4 more
  • Boston, Massachusetts
  • +1 more
Feb 6, 2020

DLBCL - Diffuse Large B Cell Lymphoma, Follicular Lymphoma Trial in Xiamen (Lenalidomide combined with G-CHOP (LO CHOP))

Recruiting
  • DLBCL - Diffuse Large B Cell Lymphoma
  • Follicular Lymphoma
  • Lenalidomide combined with G-CHOP (LO CHOP)
  • Xiamen, Fujian, China
    Bing Xu
Nov 28, 2023

Hematologic Malignancies Trial in Worldwide (Nemtabrutinib)

Recruiting
  • Hematologic Malignancies
  • Torrance, California
  • +51 more
Jan 12, 2023

Mantle Cell Lymphoma Trial in China (High dose, Low dose)

Not yet recruiting
  • Mantle Cell Lymphoma
  • High dose
  • Low dose
  • Bengbu, Anhui, China
  • +20 more
Jul 28, 2023

Waldenstrom Macroglobulinemia, Multiple Myeloma, Chronic Lymphocytic Leukemia Trial in Worldwide (Iopofosine I 131 single dose,

Recruiting
  • Waldenstrom Macroglobulinemia
  • +8 more
  • Iopofosine I 131 single dose
  • +2 more
  • Redlands, California
  • +42 more
Dec 30, 2022

Relapsed/Refractory Non-Hodgkin Lymphoma Trial in Duarte, Amsterdam (BMS-986458, Rituximab)

Not yet recruiting
  • Relapsed/Refractory Non-Hodgkin Lymphoma
  • Duarte, California
  • +1 more
Oct 13, 2023

Diffuse Large B-cell Lymphoma Recurrent, Diffuse Large B Cell Lymphoma Refractory Trial in Hangzhou (Anlotinib HCl, Rituximab,

Recruiting
  • Diffuse Large B-cell Lymphoma Recurrent
  • Diffuse Large B Cell Lymphoma Refractory
  • Anlotinib hydrochloride, Rituximab, gemcitabine, oxaliplatin
  • Hangzhou, Zhejiang, China
    Zhejiang Cancer Hospital
Oct 12, 2023

PET/CT Vs Bone Marrow Biopsy in Exclusion of Bone Marrow

Not yet recruiting
  • Lymphoma
  • positron emission tomography for exclusion of bone marrow infiltration in lymphoma
  • (no location specified)
Oct 28, 2022

Lymphoma-associated Hemophagocytic Lymphohistiocytosis

Recruiting
  • Lymphoma
  • Hemophagocytic Lymphohistiocytoses
    • Birmingham, Alabama
      University of Alabama at Birmingham
    Jun 1, 2023

    Follicular Lymphoma, Diffuse Large B Cell Lymphoma, Marginal Zone Lymphoma Trial in France (Atezolizumab, Obinutuzumab,

    Completed
    • Follicular Lymphoma
    • +3 more
    • Angers, France
    • +24 more
    Jan 9, 2023

    Follicular Lymphoma, B-Cell Lymphoma, Mantle Cell Lymphoma Trial in New York (Tazemetostat Pill)

    Not yet recruiting
    • Follicular Lymphoma
    • +3 more
    • Tazemetostat Pill
    • New York, New York
      Weill Cornell Medicine/NewYork-Presbyterian Hospital
    Jun 28, 2023

    Relapsed or Refractory B-cell Lymphoma, Diffuse Large B-cell Lymphoma (DLBCL), Follicular Lymphoma (FL) Trial in Beijing

    Recruiting
    • Relapsed or Refractory B-cell Lymphoma
    • +6 more
    • Beijing, China
      Beijing Cancer Hospital
    Feb 6, 2023

    T-cell Lymphoma, NK-Cell Lymphoma, T-cell Prolymphocytic Leukemia Trial in United States (Optional Blood Sample, Optional Nail

    Recruiting
    • T-cell Lymphoma
    • +30 more
    • Optional Blood Sample
    • Optional Nail Sample
    • Duarte, California
    • +25 more
    Jul 28, 2023

    Relapsed or Refractory CD19+ B-cell Lymphoma, Relapsed or Refractory Chronic Lymphocytic Leukemia, Relapsed or Refractory Small

    Recruiting
    • Relapsed or Refractory CD19+ B-cell Lymphoma
    • +2 more
    • TBI-2001
    • +2 more
    • Toronto, Ontario, Canada
      Princess Margaret Cancer Centre
    Jul 26, 2023

    Follicular Lymphoma, Marginal Zone Lymphoma, Indolent Non-hodgkin Lymphoma Trial in Boston (Obinutuzumab, Glofitamab)

    Not yet recruiting
    • Follicular Lymphoma
    • +2 more
    • Boston, Massachusetts
      Dana-Farber Cancer Institute
    Mar 13, 2023

    Patients Undergoing Follicular Lymphoma Clinical Research

    Not yet recruiting
    • Follicular Lymphoma
      • San Francisco, California
        Power Life Sciences
      Sep 15, 2023

      Lymphoma, B-Cell Trial in Belgium, France (Valemetostat tosylate)

      Recruiting
      • Lymphoma, B-Cell
      • Valemetostat tosylate
      • Bruges, Belgium
      • +21 more
      Jan 9, 2023

      T Cell Lymphoma Trial in New Haven (Mogamulizumab, DA-EPOCH Protocol)

      Not yet recruiting
      • T Cell Lymphoma
      • New Haven, Connecticut
        Yale Smilow Cancer Hospital
      Aug 14, 2023

      Hemophagocytic Lymphohistiocytoses, Lymphoma Trial in Beijing (cytokine)

      Not yet recruiting
      • Hemophagocytic Lymphohistiocytoses
      • Lymphoma
      • cytokine
      • Beijing, Beijing, China
        Zhao Wang
      Oct 27, 2022

      Lymphoma, Lymphoma Cns Trial in Boston (Fludarabine, Cyclophosphamide, Axicabtagene Ciloleucel)

      Recruiting
      • Lymphoma
      • Lymphoma Cns
      • Boston, Massachusetts
      • +1 more
      Jan 3, 2023

      Follicular Lymphoma Trial in New York (Mosunetuzumab, Tazemetostat Pill)

      Not yet recruiting
      • Follicular Lymphoma
      • New York, New York
        Weill Cornell Medicine/NewYork-Presbyterian Hospital
      Aug 8, 2023